Institution
National Cancer Center Hospital
Also known as: 国立がん研究センター中央病院
- 216running trials
- 97closed trials
- 1researcher
- 20,288publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Not yet recruiting
A Study of LY4336619 in Adult Participants With Advanced Solid Tumors
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
Recruiting
Recruiting
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
Recruiting
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Recruiting
Recruiting
Active, not recruiting
CoSMAP Trial: SP-EA vs MP-TA Robot-Assisted Radical Prostatectomy
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Showing 50 of 216.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer40 recruiting
- Colorectal cancer18 recruiting
- Gastric and oesophageal cancer18 recruiting
- Ovarian cancer16 recruiting
- Pancreatic cancer14 recruiting
- Childhood cancers11 recruiting
- Bladder cancer9 recruiting
- Endometrial cancer9 recruiting
- Head and neck cancer9 recruiting
- Liver and biliary tract cancer8 recruiting
- Cervical cancer7 recruiting
- Prostate cancer6 recruiting
- Sarcoma6 recruiting
- Melanoma5 recruiting
- Metastatic breast cancer5 recruiting
- Triple-negative breast cancer4 recruiting
- Neuroendocrine tumours3 recruiting
- Thyroid cancer3 recruiting
- Follicular lymphoma2 recruiting
- Glioblastoma2 recruiting
- Thymoma and thymic carcinoma2 recruiting
- Brain metastases1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
Closed trials
Recruiting
Completed
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Terminated
Completed
Completed
Terminated
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Recruiting
Completed
Completed
Terminated
Recruiting
Terminated
Terminated
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Completed
Completed
Terminated
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Completed
Completed
Completed
ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer
Completed
Completed
Completed
AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
Completed
Completed
Terminated
Terminated
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
Completed
Completed
Completed
Completed
Completed
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Completed
Terminated
Completed
Completed
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Showing 50 of 97.
Registry name variants (36)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
National Cancer Center Hospital
Chuo Ku, Tokyo 104-0045
117 trials
National Cancer Center Hospital
Tokyo, 104-0045
82 trials
National Cancer Center Hospital
Chūōku, 104-0045
57 trials
National Cancer Center Hospital
Tokyo, Chuo-ku, 104-0045
14 trials
National Cancer Center Hospital
Chūō, 104-0045
8 trials
National Cancer Center Hospital
Cho-ku, Tokyo 104-0045
3 trials
NCT06876649A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Contact: Koji Izutsu (principal investigator)
NCT04579380Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
National Cancer Center Hospital
Chuo-ku, Tokyo, 104-0045
2 trials
National Cancer Center Hospital
Tsukiji, Tokyo 104-0045
2 trials
National Cancer Center Hospital (Site 1702)
Tokyo, 104-0045
2 trials
National Cancer Centre Hospital
Tokyo, 104-004
2 trials
NCT05077384Open-label Study of Surufatinib in Japanese Patients
NCT07806266EORTC Metastatic Breast Cancer Module Development
Contact: Hiroto Ishiki
National Cancer Center Hospital
Chou-ku, 104-0045
1 trial
National Cancer Center Hospital (JPN-001)
Tokyo
1 trial
National Cancer Center Hospital (NCCH)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0005)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0026)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0103)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0179)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0307)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0561)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0601)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0650)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0651)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0767)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 0910)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 1003)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 1102)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 1172)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 1322)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 2001)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 2500)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 2602)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 2605)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 2606)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 2612)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 4015)
Tokyo, 104-0045
1 trial
National Cancer Center Hospital (Site 9001)
Tokyo, 104-0045
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer158 works · 114 trials
- Gastric and oesophageal cancer124 works · 49 trials
- Colorectal cancer84 works · 40 trials
- Sarcoma43 works · 16 trials
- Pancreatic cancer35 works · 33 trials
- Ovarian cancer31 works · 36 trials
- Head and neck cancer23 works · 20 trials
- Brain metastases17 works · 3 trials
- Diffuse large B-cell lymphoma16 works · 8 trials
- Neuroendocrine tumours15 works · 8 trials
- Endometrial cancer14 works · 12 trials
- Follicular lymphoma14 works · 7 trials
- Cytomegalovirus infection12 works · 0 trials
- Mesothelioma8 works · 1 trial
Institution data: ROR 053hhpd64 (CC0-1.0)Updated 15 Nov 2026